Form 4: Madrigal Director Sells $16M in Stock

Madrigal Pharmaceuticals Director Rebecca Taub exercised stock options and sold over 46,000 shares for approximately $16.2 million under a pre-arranged trading plan.

Summary

• Director Rebecca Taub exercised stock options for 46,463 shares of Madrigal Pharmaceuticals common stock at an exercise price of $9.45 per share.
• Concurrently, Taub sold 46,463 shares of common stock in multiple transactions on August 11 and August 12, 2025.
• The sales were executed at weighted average prices ranging from $350.1773 to $359.7108 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025.
• Following these transactions, Rebecca Taub directly holds 461,044 shares of common stock.
• Additionally, 655,540 shares are indirectly held by SQN LLC, where Taub is a managing member, with beneficial ownership disclaimed except for pecuniary interest.

Sentiment

Score: 6

Explanation: The filing details a director's planned exercise of stock options and subsequent sale of shares at a significant profit, which is a routine event for insiders monetizing equity compensation. The use of a Rule 10b5-1 plan mitigates any negative sentiment typically associated with insider selling, as it indicates pre-scheduled transactions rather than a reaction to adverse company developments.

Positives

• Director Rebecca Taub realized significant gains by exercising stock options at a low price ($9.45) and selling shares at high market prices (averaging over $350).
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a systematic approach to managing equity rather than a reaction to immediate negative news.

Negatives

• Significant insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces the insider's direct stake in the company.

Future Outlook

Not applicable for this type of filing, which primarily reports insider transactions.

Industry Context

Not applicable for this type of filing, which primarily reports insider transactions.

Corporate Governance

Related Party Transactions

• 655,540 shares are indirectly held by SQN LLC, where Rebecca Taub and her spouse are managing members. Rebecca Taub disclaims beneficial ownership of these securities except to the extent of her pecuniary interest.

Stakeholder Impact

• Shareholders: The sale of a significant number of shares by a director could be viewed with mixed sentiment; while it is a planned transaction, it still represents a reduction in direct insider ownership. However, the 10b5-1 plan context generally lessens negative interpretations.

Key Dates

Keywords

Madrigal Pharmaceuticals, MDGL, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Rebecca Taub, 10b5-1 Plan, Director, Pharmaceutical